Language And Country


14 Boulevard Royal L-2449 Luxembourg
Monday to Friday
8.30 am to 5 pm
Chaussée de La Hulpe, 120 – 1000 Brussels
Kortrijksesteenweg 218 – 9830 Sint-Martens-Latem
Monday to Friday
8.30 am to 4.30 pm

MENU - Mon Compte

Détail d'un fonds

Funds Detail

BL Fund Selection Equities

Equity fund of funds

Data as of 20/01/2021

Risk level

Recommended investment horizon : > 8 years


Average annual performance since launch 5,27 %

Performance as at 20/01/2021

2018-11,13 %
201925,39 %
202013,65 %
Since 01/01/20213,23 %
Over the last 12 months14,68 %
Over 3 years27,28 %
Since launch169,72 %
Asset breakdown
Equities93,41 %
Hedged Equities3,32 %
Absolute Return2,47 %
Cash0,80 %
Breakdown by currency
USD58,46 %
EUR33,72 %
JPY7,82 %
Main positions
Lindsell Train Global Equity - Accum Ptg C USD CAP7,88 %
GuardCap UCITS Global Equity - I USD CAP6,75 %
Schroder International Selection Asian Total Return - C CAP6,35 %
Threadneedle (Lux) Global Focus - IU CAP6,30 %
Bakersteel Global Precious Metals - I EUR CAP5,64 %


Investment objective and policy

This fund has a minimum net equity exposure of 75% and invests in UCITS and other UCIs with no geographical, sector or currency restriction. The remaining assets may be invested in bond funds, cash or any other type of transferable security that is listed or traded on regulated markets. The emphasis is on international diversification of investments and flexibility in terms of themes and sectors that may potentially be present within the fund.

Management report - 4th Quarter 2020

The health situation was still difficult at the end of the year, forcing many countries to partially shut down their economies again. The announcement of very promising results from Pfizer (followed by Moderna) on a Covid-19 vaccine with efficacy rates of over 90% spurred the markets in the fourth quarter. Although the vaccines will not be available on a large scale before the Spring, they are already allowing the markets to see a clearer way out of the health crisis at last and envisage a gradual return to normal in the second half of 2021. In the last few months, the markets were also buoyed by the results of the US presidential election. Joe Biden's victory offers the prospect of the trade war easing, with China and with other partners around the world. After months of bitter discussions, an agreement was finally reached between the United Kingdom and the European Union in the closing days of 2020. This tide of optimism led to strong gains on the equity markets. The MSCI World index added 9.4% (in EUR), driven by emerging markets (+14.7% in EUR) and European markets (+10.9%), which have a greater proportion of cyclical stocks, the quarter's main beneficiaries. The US markets gained 7.5% (in EUR). BL Fund Selection Equities benefited from this favourable environment for risky assets to grow by 8.7%. It underperformed the average of its peers: with its bias towards the quality growth style, the fund suffered from the poor relative performance of the underlying funds in an environment that was more favourable to cyclical stocks and value management. Most of the equity funds in the portfolio underperformed their respective indexes. In addition, the gold-mining funds posted negative performance overall for the quarter as the price of gold consolidated after a good start to the year. Notable in terms of movements was the exit of G Fund Avenir Europe following the announcement of the fund manager’s departure. It was replaced by a fund that is similar in terms of management style, Berenberg European Focus.

General information

Net Asset Value 
Calculated Every business day
NAV class B capitalisation shares (20/01/2021)269,72 EUR
CODESISIN capitalisation code : LU0135980968
WKN capitalisation code : 762210
SICOVAM capitalisation code : 509654
Net assets (million)94,79 EUR
Launch date03/10/2001

Détail fonds - disclaimer

Before making any decision to subscribe, customers must ensure they have understood the product, having measured the risks associated with it and consulted their own advisers on the appropriateness of the product for their particular financial situation, taking into account legal, tax and accounting aspects. This fact sheet has been drawn up for information purposes and shall in no event be considered a solicitation to buy or an offer to sell securities or other financial instruments. Information provided to the interested party does not constitute legal or fiscal advice and the Bank shall not be held liable for such information. The securities referred to in this document may cause the investor to incur significant risk and may not be appropriate for all investors. Such risks include market risks, high volatility, credit risk, liquidity risk and interest-rate risk. There is no guarantee that the securities described in this document will achieve their investment objectives. Past performance is no indication of future returns. The Bank shall not be held liable for the future performance of these securities. Potential investors must ensure that they understand the risks of investing in such products and should only take an investment decision after giving careful consideration, together with their professional advisers, to the appropriateness of this investment to their specific financial situation, particularly with regard to legal, tax and accounting aspects. We have made every effort to verify that the information presented in this document is correct, in particular the estimated values, opinions and other estimates. Nevertheless, no guarantee can be given as to the validity, timeliness, completeness, correctness or accuracy of the information, which is provided for guidance only. Information may be subject to change without prior notice.

Page détail fonds - Retour au tableau